Medical Device GMA

General considerations for medical device preliminary analysis:

·     Status of GHTF (EU, US, Canada, Japan, Australia) country approval, country of origin approval, and/or ISO 13485 certificate

·     Product classification under current approvals

·     Intended purpose and IFU (Instructions for Use) documentation

·     Available product technical files such as: risk management file, clinical evaluation report, IEC 60601 series test report

·     Customer local representative arrangements

·     Factory location

·     Wireless function/technology if applicable, and specifications

We can assist you for market access in the countries below – with a focus on:

·     Preliminary analysis/Classification identification

·     Product testing arrangements/Certification process advice

·     Required documentations/Coordination for site audit

Brazil – INMETRO Certification

·     Assistance for mandatory INMETRO (National Institute of Metrology, Quality and Technology)  (Ordinance 54) certification based on IEC 60601 series

·     Reports need to be issued by ILAC or IAAC labs – less than 2 years, or 4 years for large-scale equipment

·     Factory inspection and applicant audit is required

·     5 years validity; Certification Maintenance every 15 months

S. Korea – MFDS

·     Assistance for application of type test. If CB report and certificate are available, upon review, the type test can be skipped

·     Assistance for technical document review (Class Ⅱ to Korean CB, Class Ⅲ ~ Class Ⅵ to MFDS)

·     Assistance and coordination of GMP Audit (QMS Inspection)

·     Application of MFDS product approval (to MFDS)

Russia – Registration and Gost-R Certification

·     Class I, IIa, IIb, III

·     ROSZDRAVNADZOR (RNZ, Ministry of Health) registration, Gost-R declaration

·     Local technical testing (safety, EMC, performance, biocompatibility) only after obtaining permission from RNZ

·     Clinical data assessment (clinical investigation or documentation review normally for Class I) can only be issued by RNZ-accredited hospital in Russia

Saudi Arabia – SFDA Marketing Authorization

·     Class I, IIa, IIb, III

·     Based on prior approval in GHTF founding countries (EU, US, Canada, Japan, Australia), such as CE, FDA, etc.

·     Applicant must be an authorized representative licensed by SFDA, except for Class I non-sterile products

·     Distributors/importers need to list the product after Marketing Authorization

·     Must consider Saudi deviation: 127 or 220 or 380 V, 60Hz

·     Validity up to 3 years, depending on the remainder of GHTF country approval

 


Loading...